Haemonetics Quarterly Balance Sheet
NYSE: HAEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Haemonetics financial position
As of Jun 27, 2026, Haemonetics reported total assets of $2.37 billion, down 3.9% from a year earlier against total liabilities of $1.53 billion. Shareholders' equity stood at $837.1 million, or 35.4% of assets. The company held $223.4 million in cash and equivalents against $1.17 billion of debt, a net debt position of $950.8 million.
The current ratio (current assets divided by current liabilities) was 3.08, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.40.
Summary generated from market data by MetaCap's automated system. Methodology
Haemonetics balance sheet (quarterly)
| Quarter (USD) | Q1 20272026-06-27 | Q4 20262026-03-28 | Q3 20262025-12-27 | Q2 20262025-09-27 | Q1 20262025-06-28 | Q4 20252025-03-29 | Q3 20252024-12-28 | Q2 20252024-09-28 | Q1 20252024-06-29 | Q4 20242024-03-30 | Q3 20242023-12-30 | Q2 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 223.38M | 245.44M | 363.37M | 296.43M | 292.90M | 306.76M | 320.85M | 299.28M | 344.43M | 178.80M | 193.98M | 351.00M |
| Receivables | 216.07M | 216.85M | 195.71M | 207.07M | 200.75M | 202.66M | 211.95M | 213.53M | 201.49M | 206.56M | 211.61M | 174.25M |
| Inventory | 306.74M | 306.37M | 321.19M | 336.21M | 360.53M | 365.14M | 359.61M | 382.11M | 373.79M | 317.20M | 304.02M | 285.83M |
| Total Current Assets | 810.83M | 834.88M | 943.67M | 899.68M | 913.16M | 934.98M | 1.01B | 955.90M | 978.58M | 768.90M | 764.98M | 865.74M |
| Property, Plant & Equipment | 303.78M | 305.76M | 297.23M | 292.48M | 286.87M | 284.05M | 286.11M | 300.48M | 302.48M | 311.36M | 318.67M | 307.77M |
| Goodwill | 656.88M | 656.37M | 606.83M | 606.10M | 607.30M | 604.27M | 605.27M | 616.16M | 613.35M | 565.08M | 555.00M | 465.40M |
| Intangible Assets | 434.51M | 447.65M | 419.73M | 428.36M | 450.63M | 455.74M | 465.62M | 487.84M | 494.94M | 406.12M | 429.27M | 250.50M |
| Total Assets | 2.37B | 2.40B | 2.49B | 2.44B | 2.46B | 2.45B | 2.53B | 2.53B | 2.54B | 2.20B | 2.20B | 2.01B |
| Accounts Payable | 56.34M | 51.06M | 48.69M | 61.69M | 46.01M | 67.00M | 62.99M | 69.24M | 76.93M | 73.36M | 56.84M | 80.16M |
| Short-Term Debt | 4.96M | 5.01M | 304.75M | 304.33M | 303.95M | 303.56M | 5.08M | 5.43M | 5.11M | 10.23M | 13.74M | 13.57M |
| Total Current Liabilities | 263.24M | 282.60M | 539.87M | 548.32M | 531.41M | 578.11M | 253.23M | 273.95M | 260.08M | 300.38M | 261.75M | 264.21M |
| Long-Term Debt | 1.17B | 1.22B | 919.99M | 920.39M | 920.83M | 921.23M | 1.22B | 1.22B | 1.22B | 797.56M | 856.85M | 748.66M |
| Total Liabilities | 1.53B | 1.60B | 1.58B | 1.59B | 1.58B | 1.63B | 1.62B | 1.65B | 1.64B | 1.24B | 1.26B | 1.12B |
| Shareholders' Equity | 837.10M | 796.32M | 911.45M | 849.17M | 882.30M | 820.84M | 906.86M | 878.85M | 905.37M | 959.96M | 943.32M | 893.66M |
| Retained Earnings | 311.52M | 279.34M | 381.09M | 336.32M | 356.05M | 352.17M | 392.23M | 368.54M | 386.64M | 360.46M | 340.10M | 308.90M |
| Total Debt | 1.17B | 1.22B | 1.22B | 1.22B | 1.22B | 1.22B | 1.22B | 1.22B | 1.22B | 807.79M | 870.59M | 762.23M |
| Net Cash (Debt) | -950.77M | -979.14M | -861.37M | -928.30M | -931.88M | -918.02M | -903.99M | -925.67M | -879.16M | -628.99M | -676.61M | -411.22M |
| Shares Outstanding | 45.47M | 45.25M | 46.83M | 46.75M | 48.16M | 48.22M | 50.24M | 50.38M | 51.15M | 50.79M | 50.79M | 50.74M |
This table shows 12 quarterly periods of Haemonetics's balance sheet, from Q1 2027 back to Q2 2024, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow HAE's reporting calendar. What is a balance sheet?